A group of neuroscientists has retracted a paper published earlier this last year in Diabetes after realizing that a figure that took up a whole page of the paper may not have been quite right.
Here’s the notice for “Blockade of receptor for advanced glycation end products in a model of type 1 diabetic leukoencephalopathy”: Continue reading Authors retract Diabetes paper after submitting it “without knowledge of inherent errors”
A Brazilian author whose attorneys were the first to send the now-shuttered Science Fraud site a cease-and-desist letter has now had a paper retracted.
As Retraction Watch readers may know, Science Fraud shut down earlier this week in response to legal threats. Those threats were preceded by a cease-and-desist letter last month from attorneys for Rui Curi, of the University of Sao Paulo.
Curi’s work had been scrutinized by Science Fraud in a number of posts, with allegations of duplicated bands and re-used Western blots. With a gnawing suspicion that some of our more erudite readers will take issue with our use of “irony” here, Continue reading Irony? Paper by author whose attorneys sent cease-and-desist letter to Science Fraud retracted
Paul Muchowski, a neuroscience researcher at the Gladstone Institute of Neurological Disease in San Francisco, faked data in multiple grant applications, according to findings released today by the Office of Research Integrity (ORI).
In a funded NIH grant, R01 NS054753-06A1, and two submitted grant applications, R01 NS054753-06 and R01 NS047237-06, ORI says that Muchowski “knowingly and intentionally” committed “research misconduct by falsifying and fabricating data” as follows:
The Office of Research Integrity (ORI) has sanctioned a former Texas Tech postdoc for using data that had actually been generated before he joined the lab in a paper as if it were new.
Shuang-Qing Zhang, according to today’s announcement by the ORI, “engaged in research misconduct by the falsification and fabrication of plagiarized data” in a paper he claimed to have written with his supervisor, Reza Mehvar, “Determination of dextra-methylprednisolone conjugate with glycine linker in rat plasma and liver by high-performance liquid chromatography and its application in pharmacokinetics,” first published online in Biomedical Chromatography in 2009. [see update at end of post]
The work was supported by the National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH), grant R01 GM069869. The ORI found that Zhang had: Continue reading ORI sanctions former Texas Tech postdoc for falsification, fabrication, plagiarism
A group of smoking researchers — no, not scientists who are on fire; scientists who study the effects of tobacco smoke — has retracted a 2009 article after deciding that they were no longer “satisfied with the quality of the data.”
The paper, “Cigarette Smoke–induced Oxidative/Nitrosative Stress Impairs VEGF- and Fluid Shear Stress–Mediated Signaling in Endothelial Cells,” came from the lab of Irfan Rahman, a lung disease expert at the University of Rochester. It appeared online in 2009 in Antioxidants & Redox Signaling, which will be familiar to readers watching the case of Dipak Das.
As the notice explains: Continue reading Scientists retract paper because they’re “not satisfied with the quality of some of the data”
A contested retraction in Stem Cells and Development has left the Queensland University of Technology (QUT) graduate student who fought for it in limbo, uncertain if he will earn his PhD. And many of those who didn’t want the paper retracted have a significant financial interest in a company whose work was promoted by the research — despite any lack of disclosure in the now-retracted paper.
Here’s the notice: Continue reading Stem cell retraction leaves grad student in limbo, reveals tangled web of industry-academic ties
The U.S. Office of Research Integrity is investigating work done at a Caltech lab after researchers there couldn’t replicate it, and retracted a paper based on the findings.
Here’s the notice, which ran this week in the Proceedings of the National Academy of Sciences (PNAS): Continue reading ORI investigating work from Caltech lab as PNAS paper is retracted
Here at Retraction Watch, we’ve covered retractions for misconduct, journal errors, editorial system hacking and even no particular reason.
And that’s just in the last week.
However, we’ve identified a new reported reason: carelessness. A paper in Molecular and Cellular Biochemistry claimed to show how a tiny RNA causes fat cells to die.
Instead, the paper died.
Turned out that rather than describe previously published data, the authors say they inadvertently included a figure that had already appeared in another paper.
The retraction for “miR-598 induces replicative senescence in human adipose tissue-derived mesenchymal stem cells via silent information regulator 1,” reads, in full: Continue reading RNA paper retracted for “carelessness in including some of the figures”
The Journal of Neuroscience has retracted a 2011 paper by an international group of scientists, including the prominent Maryland researcher Ronald Dubner, but readers won’t know why.
As the notice “explains“: Continue reading Journal of Neuroscience retraction, typically opaque, from author with history of errors
Neuroscience has retracted a 2009 paper by a team of Korean sports researchers for what appear to be figure irregularities. But the journal’s handling of the case is puzzling and unhelpful.
The article, “Treadmill exercise improves cognitive function and facilitates nerve growth factor signaling by activating mitogen-activated protein kinase/extracellular signal-regulated kinase1/2 in the streptozotocin-induced diabetic rat hippocampus,” came out of Korea National Sport University, among others. It seemed to suggest that exercise could make diabetic rats smarter.
According to the retraction notice: Continue reading “Serious errors” in figures prompt concerning Neuroscience retraction